Peripheral Vasodilator Drugs Market (Drug Type: Calcium Channel Blockers, Direct-acting Vasodilators, Alpha-adrenergic Blockers, Potassium Channel Activators, Nitrates, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Publish Date: Mar 2023

Report Code: TMR3858A

Publisher: Transparency

Single User License: $5795

Explore Our Services

Already a member? Login here.

Report Highlights

Peripheral Vasodilator Drugs Market – Scope of Repor

TMR’s report on the global peripheral vasodilator drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global peripheral vasodilator drugs market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peripheral vasodilator drugs market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the peripheral vasodilator drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peripheral vasodilator drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peripheral vasodilator drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peripheral vasodilator drugs market.

The report delves into the competitive landscape of the global peripheral vasodilator drugs market. Key players operating in the global peripheral vasodilator drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peripheral vasodilator drugs market profiled in this report.

Key Questions Answered in Global Peripheral Vasodilator Drugs Market Report

  • What is the sales/revenue generated by peripheral vasodilator drugs across all regions during the forecast period?
  • What are the opportunities in the global peripheral vasodilator drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2023-2031
Units considered $ Million
Segments covered By Drug Type, By Distribution Channel, By Region
Industry covered Pharmaceutical
Countries covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies studied
  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • GSK plc
  • AstraZeneca
  • Merck & Co., Inc.
  • Sanofi
  • Bayer AG
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris, Inc.
  • Lupin

Peripheral Vasodilator Drugs Market – Research Objectives and Research Approach

The comprehensive report on the global peripheral vasodilator drugs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peripheral vasodilator drugs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peripheral vasodilator drugs market.

  • Table 1 : Global Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 2 : Global Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 3 : Global Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 4 : North America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 5 : North America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 6 : North America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 7 : Europe Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 8 : Europe Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 9 : Europe Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 10 : Asia Pacific Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 11 : Asia Pacific Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 12 : Asia Pacific Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 13 : Latin America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 14 : Latin America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 15 : Latin America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 16 : Middle East & Africa Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 17 : Middle East & Africa Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 18 : Middle East & Africa Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Figure 1 : Global Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Peripheral Vasodilator Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 3 : Global Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031
  • Figure 4 : Global Peripheral Vasodilator Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 5 : Global Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031
  • Figure 6 : Global Peripheral Vasodilator Drugs Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 7 : Global Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Region, 2023–2031
  • Figure 8 : North America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 9 : North America Peripheral Vasodilator Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 10 : North America Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031
  • Figure 11 : North America Peripheral Vasodilator Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 12 : North America Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031
  • Figure 13 : North America Peripheral Vasodilator Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 14 : North America Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Country, 2023–2031
  • Figure 15 : Europe Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 16 : Europe Peripheral Vasodilator Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 17 : Europe Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031
  • Figure 18 : Europe Peripheral Vasodilator Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 19 : Europe Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031
  • Figure 20 : Europe Peripheral Vasodilator Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 21 : Europe Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
  • Figure 22 : Asia Pacific Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 23 : Asia Pacific Peripheral Vasodilator Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 24 : Asia Pacific Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031
  • Figure 25 : Asia Pacific Peripheral Vasodilator Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 26 : Asia Pacific Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031
  • Figure 27 : Asia Pacific Peripheral Vasodilator Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 28 : Asia Pacific Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
  • Figure 29 : Latin America Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 30 : Latin America Peripheral Vasodilator Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 31 : Latin America Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031
  • Figure 32 : Latin America Peripheral Vasodilator Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 33 : Latin America Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031
  • Figure 34 : Latin America Peripheral Vasodilator Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 35 : Latin America Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
  • Figure 36 : Middle East & Africa Peripheral Vasodilator Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 37 : Middle East & Africa Peripheral Vasodilator Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 38 : Middle East & Africa Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031
  • Figure 39 : Middle East & Africa Peripheral Vasodilator Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 40 : Middle East & Africa Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031
  • Figure 41 : Middle East & Africa Peripheral Vasodilator Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42 : Middle East & Africa Peripheral Vasodilator Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
  • Figure 43 : Global Peripheral Vasodilator Drugs Market Share Analysis, by Company, 2022

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Peripheral Vasodilator Drugs Market (Drug Type: Calcium Channel Blockers, Direct-acting Vasodilators, Alpha-adrenergic Blockers, Potassium Channel Activators, Nitrates, and...